Viridian Therapeutics, Inc./DE Operating Lease, Right-of-Use Asset, Amortization Expense
Viridian Therapeutics, Inc./DE (VRDN) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $700.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-02-26
- Viridian Therapeutics, Inc./DE operating lease, right-of-use asset, amortization expense for the quarter ending 2025-12-31 was $200.00K.
- Viridian Therapeutics, Inc./DE operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $200.00K, a 0.00% change year-over-year.
- Viridian Therapeutics, Inc./DE operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $200.00K, a 33.33% decline year-over-year.
- Viridian Therapeutics, Inc./DE operating lease, right-of-use asset, amortization expense for the quarter ending 2025-03-31 was $200.00K, a 0.00% change year-over-year.
- Viridian Therapeutics, Inc./DE operating lease, right-of-use asset, amortization expense for fiscal 2025 was $700.00K, a 0.00% change from fiscal 2024.
- Viridian Therapeutics, Inc./DE operating lease, right-of-use asset, amortization expense for fiscal 2024 was $700.00K, a 12.50% decline from fiscal 2023.
- Viridian Therapeutics, Inc./DE operating lease, right-of-use asset, amortization expense for fiscal 2023 was $800.00K, a 60.00% increase from fiscal 2022.
- Viridian Therapeutics, Inc./DE operating lease, right-of-use asset, amortization expense for fiscal 2022 was $500.00K, a 0.00% change from fiscal 2021.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $400.00K derived: sum of 2 quarters · filed 2026-02-26 | $600.00K derived: sum of 3 quarters · filed 2026-02-26 | $700.00K 10-K · filed 2026-02-26 | |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-05 | $400.00K derived: sum of 2 quarters · filed 2025-11-05 | $500.00K 10-Q · filed 2025-11-05 | $500.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-06-30 | $200.00K 10-Q · filed 2025-08-06 | $300.00K 10-Q · filed 2025-08-06 | $300.00K derived: sum of 3 quarters · filed 2026-02-26 | $500.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2025-03-31 | $200.00K 10-Q · filed 2025-05-06 | $100.00K derived: sum of 2 quarters · filed 2026-02-26 | $300.00K derived: sum of 3 quarters · filed 2026-02-26 | $600.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $100.00K derived: sum of 2 quarters · filed 2026-02-26 | $400.00K derived: sum of 3 quarters · filed 2026-02-26 | $700.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $200.00K 10-Q · filed 2025-11-05 | $500.00K derived: sum of 2 quarters · filed 2025-11-05 | $800.00K 10-Q · filed 2025-11-05 | $900.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $300.00K 10-Q · filed 2025-08-06 | $600.00K 10-Q · filed 2025-08-06 | $700.00K derived: sum of 3 quarters · filed 2026-02-26 | $900.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $200.00K 10-Q · filed 2025-05-06 | $400.00K derived: sum of 2 quarters · filed 2026-02-26 | $600.00K derived: sum of 3 quarters · filed 2026-02-26 | $900.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $400.00K derived: sum of 2 quarters · filed 2026-02-26 | $700.00K derived: sum of 3 quarters · filed 2026-02-26 | $800.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $200.00K 10-Q · filed 2024-11-12 | $500.00K derived: sum of 2 quarters · filed 2024-11-12 | $600.00K 10-Q · filed 2024-11-12 | $700.00K derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-06-30 | $300.00K 10-Q · filed 2024-08-08 | $400.00K 10-Q · filed 2024-08-08 | $500.00K derived: sum of 3 quarters · filed 2025-03-03 | $600.00K derived: sum of 4 quarters · filed 2025-03-03 | |
| 2023-03-31 | $100.00K 10-Q · filed 2024-05-08 | $200.00K derived: sum of 2 quarters · filed 2025-03-03 | $300.00K derived: sum of 3 quarters · filed 2025-03-03 | $400.00K derived: sum of 4 quarters · filed 2025-03-03 | |
| 2022-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $200.00K derived: sum of 2 quarters · filed 2025-03-03 | $300.00K derived: sum of 3 quarters · filed 2025-03-03 | $500.00K 10-K · filed 2025-03-03 | |
| 2022-09-30 | $100.00K 10-Q · filed 2023-11-13 | $200.00K derived: sum of 2 quarters · filed 2023-11-13 | $400.00K 10-Q · filed 2023-11-13 | $700.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-06-30 | $100.00K 10-Q · filed 2023-08-08 | $300.00K 10-Q · filed 2023-08-08 | $600.00K derived: sum of 3 quarters · filed 2024-02-27 | $700.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2022-03-31 | $100.00K 10-Q · filed 2023-05-10 | $500.00K derived: sum of 2 quarters · filed 2024-02-27 | $600.00K derived: sum of 3 quarters · filed 2024-02-27 | $700.00K derived: sum of 4 quarters · filed 2024-02-27 | |
| 2021-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $500.00K derived: sum of 2 quarters · filed 2024-02-27 | $600.00K derived: sum of 3 quarters · filed 2024-02-27 | $500.00K 10-K · filed 2024-02-27 | |
| 2021-09-30 | $100.00K 10-Q · filed 2022-11-14 | $200.00K derived: sum of 2 quarters · filed 2022-11-14 | $100.00K 10-Q · filed 2022-11-14 | -$100.00K 10-Q · filed 2021-11-05 | $300.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $100.00K 10-Q · filed 2022-08-15 | $200.00K 10-Q · filed 2022-08-15 | $200.00K derived: sum of 3 quarters · filed 2022-08-15 | $300.00K derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $100.00K 10-Q · filed 2022-05-13 | $100.00K derived: sum of 2 quarters · filed 2022-05-13 | $200.00K derived: sum of 3 quarters · filed 2022-05-13 | $300.00K derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $100.00K derived: sum of 2 quarters · filed 2021-11-05 | $200.00K derived: sum of 3 quarters · filed 2021-11-05 | $300.00K 10-K · filed 2021-03-26 | |
| 2020-09-30 | $100.00K 10-Q · filed 2021-11-05 | $200.00K derived: sum of 2 quarters · filed 2021-11-05 | $300.00K 10-Q · filed 2021-11-05 | ||
| 2020-06-30 | $100.00K 10-Q · filed 2021-08-12 | $200.00K 10-Q · filed 2021-08-12 | |||
| 2020-03-31 | $100.00K 10-Q · filed 2021-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |